Have a personal or library account? Click to login
Ampelopsin induces MDA-MB-231 cell cycle arrest through cyclin B1-mediated PI3K/AKT/mTOR pathway in vitro and in vivo Cover

Ampelopsin induces MDA-MB-231 cell cycle arrest through cyclin B1-mediated PI3K/AKT/mTOR pathway in vitro and in vivo

Acta Pharmaceutica
Volume 73 (2023): Issue 1 (March 2023)
By: Minjun Meng,  Qiaolu Yang,  Zhong Ouyang,  Qingmo Yang,  Xinyi Wu,  Yufan Huang,  Yonghui Su,  Shuanglong Chen and  Wenlin Chen  
Open Access
|Jan 2023
DOI: https://doi.org/10.2478/acph-2023-0005 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 75 - 90
Accepted on: Jul 31, 2022
|
Published on: Jan 24, 2023
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
PI3K/AKT/mTOR pathway,
cyclin B1,
breast cancer,
cell cycle arrest,
ampelopsin
Related subjects:
Pharmacy,
Pharmacy, other

© 2023 Minjun Meng, Qiaolu Yang, Zhong Ouyang, Qingmo Yang, Xinyi Wu, Yufan Huang, Yonghui Su, Shuanglong Chen, Wenlin Chen, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 73 (2023): Issue 1 (March 2023)Next article